Hy
Hyku Bio
Cambridge MAFounded 202115 employees
Private CapbiotechPrivateOncology
Platform: Targeted IFN
Market Cap
N/A
All Drugs
2
Clinical Trials
2
Failed / Terminated
0
FDA Approved
0
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Gozenesiran | HYK-8771 | NDA/BLA | 1 | PARP | LGSPTSD | ||
| HYK-8507 | HYK-8507 | Phase 1 | 1 | GLP-1R | WMGBM |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (1)